Top Markets
Coin of the day
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Classement en actions #13229
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Prix de l'action
$4.99
Capitalisation boursière
$508.03M
Changement (1 jour)
-2.48%
Changement (1 an)
2.10%
Pays
TW
Échange Ever Supreme Bio Technology Co., Ltd (6712)

Catégorie

Historique du prix de l'action pour Ever Supreme Bio Technology Co., Ltd (6712)
Prix de clôture le plus élevé : $4.88 le 2026-08-01

Prix de clôture le plus bas : $1.98 le 2018-10-01
Historique du prix de l'action de Ever Supreme Bio Technology Co., Ltd de 2018 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -4.84%
2025 8.48%
2024 -5.27%
2023 0.33%
2022 -5.52%
2021 21.39%
2020 20.06%
2019 82.02%
2018 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$541.44 38.47%
US
$1.03K 43.99%
NL
$121.01 -13.08%
AU
$142.74 492.53%
US
$749.90 5.87%
CH